Z-1469-2020 Class II Terminated
FDA device recall Z-1469-2020 was initiated by The Binding Site Group, Ltd. on Aug 12, 2018 and is designated Class II. Reason for recall: A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely… The recall status is terminated (terminated Jan 20, 2022). Affected quantity: 462 kits.
Recall details
- Product Type
- Devices
- Report Date
- Mar 18, 2020
- Initiation Date
- Aug 12, 2018
- Termination Date
- Jan 20, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 462 kits
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide distribution in the states of M.A., C.A., MO., NC, MN, VA, WA, and IL and country of Canada.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1469-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.